AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
Yuxuan Zhu,* Ting Yuan,* Yuan Zhang, Jianyou Shi, Lan Bai, Xingmei Duan, Rongsheng Tong, Lei Zhong Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu,...
Saved in:
Main Authors: | Zhu Y (Author), Yuan T (Author), Zhang Y (Author), Shi J (Author), Bai L (Author), Duan X (Author), Tong R (Author), Zhong L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles
by: Kashi Javaherian, et al.
Published: (2011) -
Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.
by: Nandy C López, et al.
Published: (2010) -
Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
by: Gerard Esteruelas, et al.
Published: (2022) -
β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
by: Jiali Hu, et al.
Published: (2021) -
Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
by: Nikola Plenagl, et al.
Published: (2019)